NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.5901
-0.0179 (-2.94%)
May 28, 2026, 11:29 AM EDT - Market open
NEXGEL Employees
NEXGEL had 19 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
19
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$592,895
Profits / Employee
-$169,211
Market Cap
5.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 19 | 0 | - |
| Dec 31, 2024 | 19 | 0 | - |
| Dec 31, 2023 | 19 | 7 | 58.33% |
| Dec 31, 2022 | 12 | 2 | 20.00% |
| Dec 31, 2021 | 10 | 2 | 25.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 201 |
| Bionano Genomics | 97 |
| Femasys | 54 |
| Nephros | 36 |
| GlucoTrack | 15 |
| Milestone Scientific | 15 |
NXGL News
- 9 days ago - NexGel announces data from institutional review board clinical study - TheFly
- 9 days ago - NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration - GlobeNewsWire
- 12 days ago - NEXGEL Earnings Call Transcript: Q1 2026 - Transcripts
- 12 days ago - NEXGEL Quarterly report: Q1 2026 - Filings
- 15 days ago - NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical - GlobeNewsWire
- 16 days ago - NEXGEL To Report First Quarter 2026 Financial Results on May 15th - GlobeNewsWire
- 22 days ago - NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors - GlobeNewsWire
- 4 weeks ago - NexGel appoints Ian Blackman as CFO - TheFly